Biomarkers in Transplant Recipients to Improve Outcomes

Description

The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.

Conditions

Solid Organ Transplantation, Bone Marrow Transplantation

Talk to us

Study Overview

On this page

Study Details

Study overview

The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.

Study of Biomarkers in Solid Organ and Bone Marrow Transplant Recipients to Better Treat Rejection

Biomarkers in Transplant Recipients to Improve Outcomes

Condition
Solid Organ Transplantation
Intervention / Treatment

-

Contacts and Locations

Pittsburgh

Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States, 15224

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Recipients of abdominal, thoracic and bone marrow allografts that are receiving inpatient and outpatient follow-up with routine laboratory tests at the University of Pittsburgh Medical Center.
  • * All Ages
  • * Subject or parents are able to read and understand the informed consent
  • * Subjects and/or their parents who are unable to read and understand informed consent.

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Pittsburgh,

Rakesh Sindhi, MD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh

Study Record Dates

2030-03